UCP2 and inflammatory bowel disease: A study in an animal model revealed that miR-133a via targeting uncoupling protein 2 (UCP2) participates in inflammatory bowel disease by altering downstream inflammation, oxidative stress and markers of energy metabolism ([93], Jin, Chen et al., 2017).